The Alabama Supreme Court on Friday allowed a patient who claims that he was harmed by taking the generic version of a Pfizer drug to continue his suit against Pfizer. The ruling stands in contrast to a U.S. Supreme Court decision that bars users of generic drugs from bringing failure-to warn suits against the manufacturers of the brand-name counterparts.
Alabama High Court Okays Suit Against Pfizer for Failure to Warn of Generic's Risks
The Litigation Daily
January 14, 2013
This article requires premium access
This article requires premium access to The AmLaw Litigation Daily. Please sign in or subscribe to read the full text.